Results 241 to 250 of about 1,293,873 (407)

Alternative approach to express Mycobacterium tuberculosis proteins in Escherichia coli

open access: yesBioTechniques, 2003
Sandeep Mukherjee   +3 more
doaj   +1 more source

Review 1 - Nature (Busby) [PDF]

open access: yes, 2009
Scarlato, Vincenzo
core  

A Modular Vaccine Platform Against SARS‐CoV‐2 Based on Self‐Assembled Protein Nanoparticles

open access: yesAdvanced Science, EarlyView.
A modular BP26 nanoparticle vaccine platform incorporating the SpyTag/SpyCatcher system enables high‐density, repetitive antigen display with post‐expression flexibility. Conjugation of the SARS‐CoV‐2 RBD to BP26 nanoparticles elicits strong humoral immunity and confers protection against viral challenge in vivo.
Seojung Lee   +6 more
wiley   +1 more source

Characterization of a novel Jumbo phage JP4 with potential to control pathogenic Escherichia coli. [PDF]

open access: yesVirol J
Zhang K   +13 more
europepmc   +1 more source

CRISPR in MOF Formulation with Enhanced Stability, Activity, and Altered PAM Specificity for Broad‐Spectrum Diagnosis of Bacterial Sepsis

open access: yesAdvanced Science, EarlyView.
CRISPR‐FLEXMO (CRISPR with flexible PAM in MOF encapsulation) integrates a PAM‐relaxed Cas12a K607R enzyme with a manganese‐coordinated MOF for broad‐spectrum diagnosis of bacterial sepsis. The MOF enhances activity and preserves functionality under heat, solvent, and chaotropic stress, supporting long‐term room‐temperature storage.
Tathagata Pal   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy